Discover the latest news on treatments and emerging drugs

Posted: Tuesday 2 April 2024

A webinar exploring the fast-changing landscape of treatments for age-related macular degeneration (AMD) will be hosted by OcuPlan this month.

Find out more

smiling-bame-nurse-patient-clinic.jpg

‘Regular injections essential in maintaining vision’

Posted: Wednesday 27 March 2024

Early diagnosis, prompt initial treatment, and regular injections help stabilise vision in most eyes with wet age-related macular degeneration (AMD), according to a new report published by the Royal College of Ophthalmologists

Find out more

All you need to know about implantable magnifying lenses for macular disease

Posted: Monday 25 March 2024

Intraocular lenses (IOLs) were the focus of our My Macular and Me webinar in March, as Dr Julie Silvestri shed light on the potential of these devices, which aim to improve vision for people living with sight loss.

Find out more

‘I didn’t appreciate the longer-term emotional impact of this disease’

Posted: Wednesday 20 March 2024

Jill, a university researcher from County Durham, described how the Macular Society’s Counselling Service gave her the “time and breathing space” to adapt after a diagnosis of an extremely rare form of macular disease.

Find out more

office workers in discussion

Enquiry explores employers’ attitudes to visually impaired employees

Posted: Tuesday 5 March 2024

The All Party Parliamentary Group (APPG) on Eye Health and Visual Impairment has launched an enquiry to find out more about how employers treat and hire blind and partially sighted people.

Find out more

Increased dose of Eylea to extend treatment intervals

Posted: Friday 1 March 2024

Renowned retinal specialist Dr Kenneth Fan has called the higher approved dose of Eylea for patients with wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO), “a pivotal moment” for the treatment of these conditions.

Find out more

Light grey eye close up

Encouraging results from light therapy study for dry AMD

Posted: Friday 1 March 2024

Early results from a study assessing the effectiveness of the Valeda Light Delivery System for treating dry age-related macular degeneration (AMD), have shown promise.

Find out more

'Talking about it is an opportunity to help people understand more about sight loss'

Posted: Thursday 29 February 2024

Leah's journey with Best disease started when she was growing up with her brother Finn, who has the condition. But, even though she knew what it was, her own eyesight was not affected.

Find out more

Nurse Looks Into Eyes Of Elderly Patient

Patients reveal communication gaps in diagnosis

Posted: Monday 5 February 2024

Patients have highlighted noticeable gaps in communication when they are first diagnosed with macular disease, or if they are considered at risk of developing the condition.

Find out more

An illustrative design showing victorian-era women in the middle of a modern street to suggest an hallucination somebody with Charles Bonnet syndrome might experience

'The more that is known about Charles Bonnet syndrome, the better'

Posted: Thursday 1 February 2024

Researchers at Royal Holloway University looking into the effectiveness of different techniques to help manage visual hallucinations are calling for more participants to take part in the first study of its kind.

Find out more

Generic Drug Image

Another new drug offers hope for Stargardt patients

Posted: Monday 29 January 2024

Another drug to potentially treat Stargardt has shown positive results in slowing down the progression of the disease in a recent trial.

Find out more

Support group consoling hug

Dedicated group for those supporting people with macular disease launches

Posted: Thursday 25 January 2024

A new dedicated support group for caregivers and those supporting people living with macular disease will launch this spring, recognising their often-overlooked needs.

Find out more